Glucose News and Research

RSS

Obese individuals who consume aspartame may have worse glucose management

Artificial sweeteners help individuals with obesity to cut calories and lose weight but may have negative health effects, according to researchers at York University's Faculty of Health.

25 May 2016

Obese teenagers may have lower levels of spexin harmone

Obese teenagers already show signs of hormonal differences from normal-weight peers that may make them prone to weight gain, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

25 May 2016

Study finds gap in screening for lipid abnormalities among adults taking antipsychotic medications

Too few adults taking antipsychotic medications are being screened for abnormalities in lipids, which include cholesterol and triglycerides, new research from the University of Colorado Anschutz Medical Campus finds.

25 May 2016

Epigenetic modification of Igfbp2 gene may increase risk of obesity and fatty liver

Scientists of the German Center for Diabetes Research led by the German Institute of Human Nutrition have shown in a mouse model that the epigenetic modification of the Igfbp2 gene observed in the young animal precedes a fatty liver in the adult animal later in life.

24 May 2016

HbA1C test can effectively detect hidden diabetes among hyperglycemia patients

A retrospective review of medical records found the HbA1C test, commonly used to diagnose and manage diabetes, can effectively detect hidden disease among hospital patients with hyperglycemia, commonly known as high blood sugar.

24 May 2016

Four major phenotypes may help improve prediction, prevention of cardiometabolic risk in prediabetes

Prediabetes is associated with increased risk of diabetes, cardiovascular disease, dementia and cancer. However, the disease risk considerably varies among subjects.

21 May 2016

Researchers identify single RCAN1 gene responsible for onset of type 2 diabetes

RESEARCHERS have identified the gene they believe is responsible for the onset of type 2 diabetes, sparking hope for treatments to prevent and possibly reverse the progressive condition.

20 May 2016

TAK1 deficit protects mice from obesity

Obesity and subsequent complications are increasing in frequency worldwide. The accumulation of adipose tissue is associated with increased inflammation, and it has been proposed that modification of proinflammatory responses could alter adipose tissue composition.

20 May 2016

Combining 2-DG with fenofibrate could provide non-toxic treatments for many cancers

A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.

19 May 2016

Flavopiridol drug could be effective strategy to impair brain cancer growth

Glioblastoma, the most common form of brain cancer is a deadly disease for which at present there is no cure. Now, researchers have published research results that show how repurposing the old drug flavopiridol could be an effective strategy to cut short sugar availability and impair cancer growth.

19 May 2016

Exposure to bright light may influence metabolism

Exposure to bright light could affect your metabolism, reports a new Northwestern Medicine study.

19 May 2016

Maintaining fitness wards off diabetes

Young adults who maintain good fitness levels into middle age reduce their risk of developing diabetes, irrespective of changes in their body mass index, show findings from the CARDIA study.

18 May 2016

CGT, University of Aberdeen announce creation of new company to develop novel technology for diabetes treatment

The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production.

18 May 2016

Insulin pump therapy can benefit all type 1 diabetes patients

Insulin pump therapy contributes to better blood glucose control in type 1 diabetes and, as pump technology continues to improve and become part of sensor-controlled feedback and artificial pancreas systems, essentially all patients would benefit from their capabilities according to a Commentary published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

18 May 2016

Research shows close similarities of canine models of human rare disorders

Professor Hannes Lohi's research group at the University of Helsinki has discovered three novel canine genes for Caffey, Raine and van den Ende-Gupta syndromes. Research reveals close similarities of the canine models of human rare disorders and highlights the potential of comparative research approach for the development of rare disease diagnostics and treatments.

18 May 2016

Ascensia Diabetes Care receives CE Mark approval for new CONTOUR™ PLUS ONE and CONTOUR™ NEXT ONE blood glucose monitoring systems

Ascensia Diabetes Care announced that it has received CE Mark (Conformité Européenne) for the new CONTOUR™ NEXT ONE and CONTOUR™ PLUS ONE blood glucose monitoring systems, the next exciting development in the evolution of self-monitoring of blood glucose for people with diabetes.

18 May 2016

Glucose News and Research

Obese individuals who consume aspartame may have worse glucose management

Obese teenagers may have lower levels of spexin harmone

Study finds gap in screening for lipid abnormalities among adults taking antipsychotic medications

Epigenetic modification of Igfbp2 gene may increase risk of obesity and fatty liver

HbA1C test can effectively detect hidden diabetes among hyperglycemia patients

Four major phenotypes may help improve prediction, prevention of cardiometabolic risk in prediabetes

Researchers identify single RCAN1 gene responsible for onset of type 2 diabetes

TAK1 deficit protects mice from obesity

Combining 2-DG with fenofibrate could provide non-toxic treatments for many cancers

Flavopiridol drug could be effective strategy to impair brain cancer growth

Exposure to bright light may influence metabolism

Maintaining fitness wards off diabetes

CGT, University of Aberdeen announce creation of new company to develop novel technology for diabetes treatment

Insulin pump therapy can benefit all type 1 diabetes patients

Research shows close similarities of canine models of human rare disorders

Ascensia Diabetes Care receives CE Mark approval for new CONTOUR™ PLUS ONE and CONTOUR™ NEXT ONE blood glucose monitoring systems

Model may guide statin treatment in diabetes patients

Pre-existing maternal diabetes still major risk factor for congenital heart defects

Sleep hormone melatonin may be responsible for type 2 diabetes risk among overnight workers

Restricted artificial pancreas use may suffice

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News